Aurinia Pharma U.S., Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.0M
Doctors Paid
11,069
Transactions
56,830
2024 Total
$3.6M
Payment Breakdown by Category
Research$6.1M (47.2%)
Food & Beverage$1.5M (11.2%)
Travel$544,155 (4.2%)
Consulting$190,528 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.1M | 678 | 47.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.0M | 1,937 | 30.8% |
| Food and Beverage | $1.5M | 49,896 | 11.2% |
| Travel and Lodging | $544,155 | 2,121 | 4.2% |
| Honoraria | $319,342 | 96 | 2.5% |
| Grant | $218,134 | 14 | 1.7% |
| Consulting Fee | $190,528 | 48 | 1.5% |
| Space rental or facility fees (teaching hospital only) | $67,812 | 11 | 0.5% |
| Education | $38,152 | 2,028 | 0.3% |
| Charitable Contribution | $25,000 | 1 | 0.2% |
Payments by Type
General
$6.8M
56,152 transactions
Research
$6.1M
678 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| LUPKYNIS Registry Study | $1.7M | 0 | 476 |
| A double-blind, randomized, placebo-controlled, single and multiple ascending dose (SAD and MAD) study to investigate the safety, tolerability and pharmacokinetics of AUR200 in healthy volunteers | $1.1M | 0 | 7 |
| A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, CONTINUATION STUDY COMPARING THE LONG-TERM SAFETY AND EFFICACY OF VOCLOSPORIN (23.7 MG TWICE DAILY) WITH PLACEBO IN SUBJECTS WITH LUPUS NEPHRITIS | $875,485 | 0 | 27 |
| 496599-Tissue localization of Cyclosporine, Voclosporine a | $573,529 | 0 | 7 |
| Effect of voclosporin on renal vessels, immune cell adherence and proximal convoluted tubules in microphysiological systems | $319,729 | 0 | 8 |
| A RANDOMIZED, CONTROLLED DOUBLE-BLIND STUDY COMPARING THE EFFICACY AND SAFETY OF VOCLOSPORIN (23.7 MG TWICE DAILY) WITH PLACEBO IN ACHIEVING RENAL RESPONSE IN SUBJECTS WITH ACTIVE LUPUS NEPHRITIS | $305,492 | 0 | 50 |
| Voclosporin in Adolescents With Lupus Nephritis (VOCAL) | $278,776 | 0 | 35 |
| AURINIA RENAL ASSESSMENTS 2: AURINIA RENAL RESPONSE IN LUPUS WITH VOCLOSPORIN (AURORA2) | $263,823 | 0 | 40 |
| 21-608 Molecular targets of Voclosporin in kidney podocytes and the effect on the actin cytoskeleton | $199,930 | 0 | 2 |
| 2904 PK study of Voclosporin and Tacrolimus when combined with Rifampin or Ketoconazole in CD-1 mouse models | $140,000 | 0 | 2 |
| Fornoni-Voclosporin in Alport Syndrome | $124,846 | 0 | 8 |
| Effect of voclosporin (VCS) on diabetes in the streptozotocin-induced type 1 diabetes | $101,424 | 0 | 4 |
| Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis | $73,559 | 0 | 3 |
| 498549-Voclosporin and Lipids Contract | $37,799 | 0 | 1 |
| 1923 Voclosporin in Alport Syndrome (PI Dr. Alessia Fornoni) | $36,275 | 0 | 4 |
| 1385 PI: Smoyer, Dr. William E. - Voclosporin effect on molecular pathways and lipids in nephrotic syndrome | $31,785 | 0 | 1 |
| A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY TO ASSESS THE EFFICACY, SAFETY AND PHARMACOKINETICS OF VOCLOSPORIN IN ADOLESCENTS WITH LUPUS NEPHRITIS | $17,964 | 0 | 1 |
| Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (Statin-DDI) | $2,737 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Brian Kirby, M.d, M.D | Rheumatology | Pensacola, FL | $49,540 | $0 |
| Michelle Petri, M.d, M.D | Rheumatology | Baltimore, MD | $49,072 | $0 |
| Walter Chatham | Rheumatology | Las Vegas, NV | $45,596 | $0 |
| Dr. Sumit Kumar, M.d, M.D | Nephrology | Dallas, TX | $45,059 | $0 |
| Dr. Michael Levin, D.o, D.O | Nephrology | Philadelphia, PA | $44,546 | $0 |
| Dr. Khaleel Sayeed, M.d, M.D | Nephrology | Chicago, IL | $38,134 | $0 |
| Dr. Vinicius Costa Diniz Domingues, M.d, M.D | Rheumatology | Daytona Beach, FL | $37,988 | $0 |
| Dr. Payam Shakouri, M.d, M.D | Nephrology | Poughkeepsie, NY | $37,772 | $0 |
| Andrew Sulich, Md, MD | Rheumatology | Saint Clair Shores, MI | $35,046 | $0 |
| Swati Arora | Nephrology | Pittsburgh, PA | $34,646 | $0 |
| Dr. Manish Jain, M.d, M.D | Student in an Organized Health Care Education/Training Program | Chicago, IL | $34,312 | $0 |
| Dr. Alexa Meara, Md, MD | Internal Medicine | Columbus, OH | $33,553 | $0 |
| Dr. Dawn Caster, M.d, M.D | Internal Medicine | Louisville, KY | $32,860 | $0 |
| Jason Rothschild, Md, MD | Nephrology | Temple Terrace, FL | $31,695 | $0 |
| Kostas Botsoglou, M.d, M.D | Internal Medicine | Cheektowaga, NY | $31,597 | $0 |
| David Batt, Md, MD | Internal Medicine | Indianapolis, IN | $30,787 | $0 |
| Arnold Silva, Md, Phd, MD, PHD | Internal Medicine | Meridian, ID | $30,742 | $0 |
| Rhonda Lambert, Md, MD | Internal Medicine | San Mateo, CA | $30,643 | $0 |
| Dr. Navid Saigal, Md, MD | Nephrology | Live Oak, TX | $28,273 | $0 |
| Dr. Narayan Agrawal, M.d, M.D | Nephrology | Fresh Meadows, NY | $28,223 | $0 |
| Dr. Julio Gonzalez-Paoli, Md, MD | Rheumatology | Tampa, FL | $28,004 | $0 |
| Dr. Gail Kerr, Md, MD | Internal Medicine | Washington, DC | $27,291 | $0 |
| Dr. Gary Rosenblum, D.o, D.O | Rheumatology | Mineola, NY | $26,587 | $0 |
| Nelson Kopyt, Do, DO | Nephrology | Allentown, PA | $26,071 | $0 |
| Robert Ettlinger, Md Facp Facr, MD FACP FACR | Rheumatology | Tacoma, WA | $25,725 | $0 |
About Aurinia Pharma U.S., Inc.
Aurinia Pharma U.S., Inc. has made $13.0M in payments to 11,069 healthcare providers, recorded across 56,830 transactions in the CMS Open Payments database. In 2024, the company paid $3.6M. The top product by payment volume is LUPKYNIS ($10.5M).
Payments were distributed across 135 medical specialties. The top specialty by payment amount is Nephrology ($1.9M to 2,968 doctors).
Payment categories include: Food & Beverage ($1.5M), Consulting ($190,528), Research ($6.1M), Travel & Lodging ($544,155).
Aurinia Pharma U.S., Inc. is associated with 1 products in the CMS Open Payments database.